MDM2 and glioblastoma: For example, in glioblastoma, CDKN2A/B alterations were mutually exclusive from many alterations in the p53 and cell cycle pathways (eg, TP53, MDM2/4, CDK4/6, and RB1), both of which include CDKN2A/B.